SPONDYLITIS, ANKYLOSING
Clinical trials for SPONDYLITIS, ANKYLOSING explained in plain language.
Never miss a new study
Get alerted when new SPONDYLITIS, ANKYLOSING trials appear
Sign up with your email to follow new studies for SPONDYLITIS, ANKYLOSING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Researchers track spondyloarthritis to predict severe outcomes
Knowledge-focused Recruiting nowThis study aims to learn more about spondyloarthritis, a group of disorders causing back and joint pain and stiffness. Researchers will observe 2000 people with the condition and their healthy relatives to find symptoms and tests that predict who may develop more severe disease. …
Matched conditions: SPONDYLITIS, ANKYLOSING
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated May 17, 2026 01:30 UTC
-
Can a 14-Day trial boost app use for back pain patients?
Knowledge-focused Recruiting nowThis study looks at how well a 14-day trial period and a short questionnaire work for people starting the Axia app for axial spondyloarthritis. About 200 participants will get one of two ways to start the app. Researchers will compare how many people successfully activate the app…
Matched conditions: SPONDYLITIS, ANKYLOSING
Phase: NA • Sponsor: Wuerzburg University Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 01:19 UTC
-
Lab study tests cannabis compounds on immune cells from arthritis and lupus patients
Knowledge-focused Recruiting nowThis study looks at how natural cannabis compounds (phytocannabinoids) affect immune cells from 100 people with chronic inflammatory diseases like rheumatoid arthritis, lupus, and inflammatory bowel disease. Researchers will take blood samples and expose the cells to different ca…
Matched conditions: SPONDYLITIS, ANKYLOSING
Sponsor: Centre Hospitalier Régional d'Orléans • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC